ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

EBS Emergent Biosolutions Inc

3,88
0,58 (17,58%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Emergent Biosolutions Inc EBS NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
0,58 17,58% 3,88 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,45 3,36 4,02 3,89 3,30
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202422:57GLOBEEmergent BioSolutions Reports First Quarter 2024 Financial..
01.5.202422:10GLOBEEmergent BioSolutions Announces Strategic Operational..
01.5.202417:03GLOBEEmergent BioSolutions Releases New Survey Findings..
30.4.202423:26GLOBEEmergent BioSolutions Announces Amendment to its Existing..
22.4.202414:05GLOBEEmergent BioSolutions to Release First Quarter 2024..
01.4.202414:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
28.3.202413:15GLOBEEmergent BioSolutions Continues to Broaden Access, Awareness..
25.3.202413:05GLOBEEmergent BioSolutions Receives NAI Status for Baltimore..
08.3.202422:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08.3.202402:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:31GLOBEEmergent BioSolutions Reports Fourth Quarter 2023 Financial..
06.3.202422:15EDGAR2Form 8-K - Current report
06.3.202412:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
05.3.202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202413:00GLOBEEmergent BioSolutions to Release Fourth Quarter & Full Year..
28.2.202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202402:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202413:25EDGAR2Form 8-K - Current report
21.2.202413:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
11.1.202413:41EDGAR2Form 8-K - Current report
09.1.202414:40EDGAR2Form 8-K - Current report
09.1.202413:30GLOBEEmergent BioSolutions to Present at the 42nd Annual J.P...
27.12.202312:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
11.12.202323:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
11.12.202313:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28.11.202313:15EDGAR2Form 8-K - Current report
28.11.202312:59GLOBEEmergent BioSolutions Receives $75 Million Contract Option..
24.11.202313:30GLOBEEmergent BioSolutions Receives NYSE Notice Regarding Delayed..
24.11.202313:17EDGAR2Form 8-K - Current report
16.11.202322:11EDGAR2Form 8-K - Current report
15.11.202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202301:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202301:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202322:22EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
08.11.202323:38GLOBEEmergent BioSolutions Reports Third Quarter 2023 Financial..
08.11.202322:21EDGAR2Form 8-K - Current report
30.10.202321:45GLOBEUPDATE: Emergent BioSolutions to Release Third Quarter 2023..
19.10.202312:30GLOBEEmergent BioSolutions to Release Third Quarter 2023..
16.10.202313:00PRNUSEmergent BioSolutions Partners with Emmitt Smith to Launch..
06.10.202301:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.10.202301:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.10.202301:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
06.10.202301:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.10.202313:42EDGAR2Form 8-K - Current report
02.10.202313:49EDGAR2Form 8-K - Current report
02.10.202313:00GLOBEEmergent BioSolutions Names Two Pharmaceutical Industry..
30.8.202312:30EDGAR2Form 8-K - Current report
30.8.202311:59GLOBEEmergent BioSolutions’ NARCAN® Nasal Spray Launches Over the..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock